MeSH Review:
Mycobacterium bovis
- A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder. Lamm, D.L., Blumenstein, B.A., Crawford, E.D., Montie, J.E., Scardino, P., Grossman, H.B., Stanisic, T.H., Smith, J.A., Sullivan, J., Sarosdy, M.F. N. Engl. J. Med. (1991)
- Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor. Shirai, T., Yamaguchi, H., Ito, H., Todd, C.W., Wallace, R.B. Nature (1985)
- Antibodies to melanoma cell and BCG antigens in sera from tumour-free individuals and from melanoma patients. Minden, P., Jarrett, C., McClatchy, J.K., Gutterman, J.U., Hersh, E.M. Nature (1976)
- A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis. Sambandamurthy, V.K., Wang, X., Chen, B., Russell, R.G., Derrick, S., Collins, F.M., Morris, S.L., Jacobs, W.R. Nat. Med. (2002)
- Regulation of arachidonic acid metabolism by macrophage activation. Scott, W.A., Pawlowski, N.A., Murray, H.W., Andreach, M., Zrike, J., Cohn, Z.A. J. Exp. Med. (1982)
- Acquired resistance but not innate resistance to Mycobacterium bovis bacillus Calmette-Guérin is compromised by interleukin-12 ablation. Thompson-Snipes, L., Skamene, E., Radzioch, D. Infect. Immun. (1998)
- Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosis. Zimhony, O., Cox, J.S., Welch, J.T., Vilchèze, C., Jacobs, W.R. Nat. Med. (2000)
- Antiviral effects of recombinant tumour necrosis factor in vitro. Mestan, J., Digel, W., Mittnacht, S., Hillen, H., Blohm, D., Möller, A., Jacobsen, H., Kirchner, H. Nature (1986)
- BCG vaccination and risk of atopy. Krause, T.G., Hviid, A., Koch, A., Friborg, J., Hjuler, T., Wohlfahrt, J., Olsen, O.R., Kristensen, B., Melbye, M. JAMA (2003)
- Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. Mazurek, G.H., LoBue, P.A., Daley, C.L., Bernardo, J., Lardizabal, A.A., Bishai, W.R., Iademarco, M.F., Rothel, J.S. JAMA (2001)
- Postoperative adjuvant chemotherapy with fluorouracil, doxorubicin, cyclophosphamide, and BCG vaccine. A follow-up report. Buzdar, A.U., Blumenschein, G.R., Gutterman, J.U., Tashima, C.K., Hortobagyi, G.N., Smith, T.L., Campos, L.T., Wheeler, W.L., Hersh, E.M., Freireich, E.J., Gehan, E.A. JAMA (1979)
- Failure of isoniazid to cure localized BCG infection. Lorber, B., Vonderheid, E.C., Swenson, R.M., Cundy, K.R. JAMA (1977)
- Adjuvant chemotherapy for stage II and III breast carcinoma. Caprini, J.A., Oviedo, M.A., Cunningham, M.P., Cohen, E., Trueheart, R.S., Khandekar, J.D., Scanlon, E.F. JAMA (1980)
- A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. Glickman, M.S., Cox, J.S., Jacobs, W.R. Mol. Cell (2000)
- Effect of Corynebacterium parvum, methanol-extraction residue of BCG, and levamisole on macrophage random migration, chemotaxis, and pinocytosis. Sher, N.A., Poplack, D.G., Blaese, R.M., Brown, T.M., Chaparas, S.D. J. Natl. Cancer Inst. (1977)
- Targeted replacement of the mycocerosic acid synthase gene in Mycobacterium bovis BCG produces a mutant that lacks mycosides. Azad, A.K., Sirakova, T.D., Rogers, L.M., Kolattukudy, P.E. Proc. Natl. Acad. Sci. U.S.A. (1996)
- Insertional mutagenesis and illegitimate recombination in mycobacteria. Kalpana, G.V., Bloom, B.R., Jacobs, W.R. Proc. Natl. Acad. Sci. U.S.A. (1991)
- The effect of Mycobacterium bovis (Bacillus Calmette-Guérin) on macrophage random migration, chemotaxis, and pinocytosis. Poplack, D.G., Sher, N.A., Chaparas, S.D., Blaese, R.M. Cancer Res. (1976)
- Cytolytic interactions between murine macrophages, tumor cells, and monoclonal antibodies: characterization of lytic conditions and requirements for effector activation. Johnson, W.J., Steplewski, Z., Matthews, T.J., Hamilton, T.A., Koprowski, H., Adams, D.O. J. Immunol. (1986)
- Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon gamma and tumor necrosis factor alpha. Flesch, I.E., Hess, J.H., Huang, S., Aguet, M., Rothe, J., Bluethmann, H., Kaufmann, S.H. J. Exp. Med. (1995)
- Recognition and destruction of Bacillus Calmette-Guerin-infected human monocytes. Molloy, A., Meyn, P.A., Smith, K.D., Kaplan, G. J. Exp. Med. (1993)
- Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. Inaba, K., Inaba, M., Naito, M., Steinman, R.M. J. Exp. Med. (1993)
- Characterization of the internalization of bacillus Calmette-Guerin by human bladder tumor cells. Kuroda, K., Brown, E.J., Telle, W.B., Russell, D.G., Ratliff, T.L. J. Clin. Invest. (1993)
- Systemic bacillus Calmette-Guérin (BCG) activates natural suppressor cells. Bennett, J.A., Rao, V.S., Mitchell, M.S. Proc. Natl. Acad. Sci. U.S.A. (1978)
- Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide. Kamijo, R., Le, J., Shapiro, D., Havell, E.A., Huang, S., Aguet, M., Bosland, M., Vilcek, J. J. Exp. Med. (1993)
- A mutation in the Icsbp1 gene causes susceptibility to infection and a chronic myeloid leukemia-like syndrome in BXH-2 mice. Turcotte, K., Gauthier, S., Tuite, A., Mullick, A., Malo, D., Gros, P. J. Exp. Med. (2005)
- Development and preclinical evaluation of a Bacillus Calmette-Guérin-MUC1-based novel breast cancer vaccine. Chung, M.A., Luo, Y., O'Donnell, M., Rodriguez, C., Heber, W., Sharma, S., Chang, H.R. Cancer Res. (2003)
- Involvement of IFN-gamma in Bacillus Calmette-Guérin-induced but not in tumor-induced sensitization to TNF-induced lethality. Cauwels, A., Brouckaert, P., Grooten, J., Huang, S., Aguet, M., Fiers, W. J. Immunol. (1995)
- Dendritic cell maturation induced by muramyl dipeptide (MDP) derivatives: monoacylated MDP confers TLR2/TLR4 activation. Uehori, J., Fukase, K., Akazawa, T., Uematsu, S., Akira, S., Funami, K., Shingai, M., Matsumoto, M., Azuma, I., Toyoshima, K., Kusumoto, S., Seya, T. J. Immunol. (2005)
- Enhanced host resistance to transplantable murine lymphosarcoma in Swiss mice by combined immunostimulation with BCG and polyinosinic-polycytidylic acid. Poduval, T.B., Seshadri, M., Sundaram, K. J. Natl. Cancer Inst. (1984)
- Tumor growth inhibition and potentiation of immunotherapy by indomethacin in mice. Lynch, N.R., Salomon, J.C. J. Natl. Cancer Inst. (1979)
- Modulation of cell-mediated alloimmunity by BCG. I. Antagonism and potentiation of immunosuppression caused by cytarabine. Murahata, R.I., Mitchell, M.S. J. Natl. Cancer Inst. (1982)
- Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa. Requirement for the expression of an antitumor response. Kavoussi, L.R., Brown, E.J., Ritchey, J.K., Ratliff, T.L. J. Clin. Invest. (1990)
- The biology and treatment of superficial bladder cancer. Torti, F.M., Lum, B.L. J. Clin. Oncol. (1984)